Listed by the USPTO as GALSTER, SAMUEL LEONARD
Tech Center 1600 • Art Units: 1623 1651 1693
This examiner grants 52% of resolved cases
GALSTER, SAMUEL LEONARD is assigned to tech center 1600 and art unit 1623. The dataset contains 117 resolved cases, an allowance rate of 52.1%, and a median of 1174 days to allowance. The allowance figure indicates a more evenly contested record than one dominated by allowances, while the timing figure suggests that successful prosecution may require patience. Interviews have a 42.2% lift, making them a significant strategic option for clarifying technical and claim issues.
The principal companies are Daiichi Sankyo Company, Limited, Haus Bioceuticals Inc., and Mirum Pharmaceuticals Inc. The leading firms are Muncy, Geissler, Olds & Lowe, P.C., CHALKER FLORES, LLP, and DUNLAP CODDING, P.C. This company and counsel mix provides useful context for pharmaceutical applicants. A well-prepared interview may be particularly valuable when paired with precise amendments and evidence addressing the cited art.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18723131 | PROCESS FOR THE BACKBONE DEPROTECTION OF OLIGONUCLEOTIDES CONTAINING A TERMINAL ALKYL PHOSPHONATE GROUP | Non-Final OA | NOVO NORDISK A/S |
| 18627239 | DOSING REGIMENS FOR USE IN PREVENTING RELAPSE OF ACUTE MYELOID LEUKEMIA FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION WITH VENETOCLAX IN COMBINATION WITH AZACITIDINE | Non-Final OA | ABBVIE INC. |
| 18269213 | MOLECULE FOR INDUCING SPONTANEOUS CALCIFICATION OF TUMOR CELLS AND USE THEREOF | Final Rejection | ZHEJIANG UNIVERSITY |
| 18571126 | TUNABLE DYNAMIC AND NON-DYNAMIC HYDROGEL SYSTEMS | Non-Final OA | The Johns Hopkins University |
| 17291588 | METHODS FOR CONSOLIDATING ANTIBIOTIC-ELUTING POLYMERIC MATERIALS | Non-Final OA | THE GENERAL HOSPITAL CORPORATION |
| 18255757 | STABLE AQUEOUS COMPOSITION FOR PRETERM TO PROMOTE EARLY POSTNAL GROWTH | Non-Final OA | SOCIETE DES PRODUITS NESTLE S.A. |
| 17616966 | METHODS OF REJUVENATING AGED TISSUE BY INHIBITING 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE (15-PGDH) | Final Rejection | The Board of Trustees of the Leland Stanford Junior University |
| 18539559 | OIL-RESISTANT AGENT | Final Rejection | DAIKIN INDUSTRIES, LTD. |
| 18704860 | ISOPROPYL-D-GLUCOPYRANOSIDE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Non-Final OA | NATIONAL TSING HUA UNIVERSITY |
| 17265387 | METHODS FOR REDUCING ABNORMAL SCAR FORMATION | Non-Final OA | CORNELL UNIVERSITY |
| 18626439 | Preparation of Chitin Nanocrystals and Nanowhiskers from Crustacean Biomass Using Ionic Liquid | Non-Final OA | Texas Tech University System |
| 17633254 | HYBRID AMIDE DERIVATIVES OF AMPHOTERICIN B | Final Rejection | The Board of Trustees of the University of Illinois |
| 18702544 | STARCH COMPOSITIONS MADE USING SATURATED STEAM | Non-Final OA | CORN PRODUCTS DEVELOPMENT, INC. |
| 18365835 | METHODS FOR THE TREATMENT OF FAMILIAL HETEROZYGOUS AND HOMOZYGOUS HYPERCHOLESTEROLEMIA WITH CYCLODEXTRINS | Non-Final OA | Beren Therapeutics P.B.C. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy52.1% of resolved applications examined by Samuel Leonard Galster were allowed (117 resolved cases), compared with 51.3% across Art Unit 1623 over the last five years.
This examiner's interview lift is +42.2 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Samuel Leonard Galster took 1,174 days on average from filing to allowance.
Samuel Leonard Galster examines applications in Art Unit 1623 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
